- Home
- APLT vs POCI Comparison
APLT vs POCI Comparison
Compare APLT & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- POCI
- Stock Information
- Founded
- APLT 2016
- POCI 1982
- Country
- APLT United States
- POCI United States
- Employees
- APLT N/A
- POCI N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- APLT Health Care
- POCI Health Care
- Exchange
- APLT Nasdaq
- POCI Nasdaq
- Market Cap
- APLT 37.5M
- POCI 32.4M
- IPO Year
- APLT 2019
- POCI N/A
- Fundamental
- Price
- APLT $0.40
- POCI $4.63
- Analyst Decision
- APLT Buy
- POCI
- Analyst Count
- APLT 7
- POCI 0
- Target Price
- APLT $6.10
- POCI N/A
- AVG Volume (30 Days)
- APLT 1.9M
- POCI 27.6K
- Earning Date
- APLT 05-20-2025
- POCI 05-14-2025
- Dividend Yield
- APLT N/A
- POCI N/A
- EPS Growth
- APLT N/A
- POCI N/A
- EPS
- APLT N/A
- POCI N/A
- Revenue
- APLT $455,000.00
- POCI $18,682,766.00
- Revenue This Year
- APLT $1,768.13
- POCI N/A
- Revenue Next Year
- APLT $361.28
- POCI N/A
- P/E Ratio
- APLT N/A
- POCI N/A
- Revenue Growth
- APLT N/A
- POCI N/A
- 52 Week Low
- APLT $0.30
- POCI $3.47
- 52 Week High
- APLT $10.62
- POCI $6.90
- Technical
- Relative Strength Index (RSI)
- APLT 46.92
- POCI 61.12
- Support Level
- APLT $0.39
- POCI $4.35
- Resistance Level
- APLT $0.44
- POCI $4.62
- Average True Range (ATR)
- APLT 0.04
- POCI 0.28
- MACD
- APLT 0.01
- POCI 0.07
- Stochastic Oscillator
- APLT 45.49
- POCI 86.61
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.